Acer Therapeutics Inc.
ACER
Revenue
371.79k
▼-528.21k▼-58.69%
30 Months ChangeAssets
14.00M
▼-646.21k▼-4.41%
3 Months ChangeLiabilities
61.75M
▲13.85M▲28.92%
3 Months ChangeFree Cash Flow
-9.02M
▼-5.98M▼-196.53%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-11-20
Form 10-Q
ID: 0000950170-23-065159
2023-11-20
Form 8-K
ID: 0001193125-23-280679
2023-11-08
Form 8-K
ID: 0001193125-23-273522
2023-11-02
Form 8-K
ID: 0001193125-23-268923
2023-08-31
Form 8-K
ID: 0001193125-23-225725
2023-08-14
Form 10-Q
ID: 0000950170-23-042436
2023-08-14
Form 8-K
ID: 0000950170-23-042407
2023-06-26
Form 8-K
ID: 0000950170-23-029735
2023-06-07
Form 8-K
ID: 0000950170-23-026809
2023-05-22
Form 8-K
ID: 0000950170-23-023449